Long-term, regular remote ischemic preconditioning improves endothelial function in patients with coronary heart

Y Liang1, Y P Li1, F He1

  • 1Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Insights

Long-term remote ischemic preconditioning (RIPre) significantly improves arterial endothelial function in patients with coronary heart disease (CHD). This intervention, involving repeated blood flow occlusion and reperfusion, enhances flow-mediated dilation and increases endothelial progenitor cells.

Area of Science:

  • Cardiovascular Research
  • Vascular Biology
  • Regenerative Medicine

Background:

  • Coronary artery disease (CHD) is a leading cause of mortality.
  • Endothelial dysfunction is a key factor in CHD pathogenesis.
  • Remote ischemic preconditioning (RIPre) shows potential for cardioprotection.

Purpose of the Study:

  • To evaluate the long-term effects of regular RIPre on human arterial endothelial function.
  • To investigate the impact of RIPre on endothelial progenitor cells and underlying molecular mechanisms in patients with CHD.

Main Methods:

  • Forty patients undergoing coronary artery bypass graft (CABG) surgery were randomized into RIPre and CHD groups (n=20 each).
  • A control group (n=20) of mastectomy patients was included.
  • RIPre involved cycles of 5-minute arterial occlusion followed by 5-minute reperfusion, repeated 4 times, 3 times daily for 20 days.
  • Endothelial function (flow-mediated dilation - FMD), CD34(+) monocyte count, eNOS expression, and STAT-3/Akt phosphorylation were assessed in arterial samples.

Main Results:

  • Long-term RIPre significantly improved FMD in the RIPre group compared to the CHD group (8.5±2.4% vs 4.9±4.2%, P<0.05).
  • Troponin levels post-CABG surgery were significantly reduced in the RIPre group.
  • RIPre activated STAT-3 signaling and increased CD34(+) endothelial progenitor cell counts.

Conclusions:

  • Regular, long-term RIPre enhances endothelial function in patients with CHD.
  • STAT-3 activation appears to be a key mechanism mediating RIPre's benefits.
  • RIPre may promote vascular repair through an increase in endothelial progenitor cells.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.1K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
423
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
866
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K